9 data-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "Dr" "P" positions at Center for Biologics Evaluation and Research (CBER) in United States

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 2 hours ago

Design. Journal of Molecular Biology. https://doi.org/10.1016/j.jmb.2019.04.021. 2019. Alexaki A., Hettiarachchi G.K., Athey J., Katneni U.K., Simhadri V., Hamasaki-Katagiri N., Nanavaty P., Lin B., Takeda

FDA Evaluation and Characterization of Neutralizing Antibodies Against Viruses Relevant to Blood-Derived Products

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 2 hours ago

of rsearch performed in our group: 1. P. Zhang et al., Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. Proc Natl Acad Sci U S A 104, 8449-8454 (2007). 2. H. Duan

FDA Fellowship - Malaria Parasite Gene Regulation

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 2 hours ago

*Applications will be reviewed on a rolling-basis. The Laboratory of Dr. Heather Painter in the Division of Bacterial, Parasitic and Allergenic Products (DBPAP) in the Center for Biologics and

FDA Fellowship - Development and Evaluation of Gene Therapy for Rare Neuromuscular and Neurological Diseases

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 2 hours ago

will generate critical safety and efficacy data to inform regulatory evaluation of these emerging therapeutic modalities. Learning Objectives: If selected, you will have the opportunity to: Develop

FDA Optimization Modeling to Support Benefit-Risk Assessment Fellowship

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 2 hours ago

, which could include Bayesian methodologies and use of artificial intelligence to systematically integrate available information for evolving benefit-risk assessment. The goal is to tackle the major

FDA Fellowship - Understanding the Role of the Manufacturing Microenvironment on the Safety and Efficacy of Cellular Therapies

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 2 hours ago

foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page  of the program website for information about the valid immigration statuses

FDA Fellowship - Immune Globulin Safety and Efficacy in Pregnant and Neonatal Populations

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 2 hours ago

information.

FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 1 day ago

the Guidelines for Non-U.S. Citizens Details page  of the program website for information about the valid immigration statuses that are acceptable for program participation. This program, administered by ORAU

FDA Prophylactic Vaccine Against Visceral Leishmaniasis Post-doctoral Fellowship

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 2 hours ago

information.